Asep Medical Holdings Inc (SEPSF)
USD 0.39
(0.0%)
USD 0.39
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.42 Million CAD | -54.46% |
| 2022 | -3.33 Million CAD | -131.11% |
| 2021 | -1.91 Million CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -589.66 Thousand CAD | 61.92% |
| 2024 Q2 | -991.4 Thousand CAD | -70.87% |
| 2023 FY | - CAD | -54.46% |
| 2023 Q3 | -1.3 Million CAD | 26.56% |
| 2023 Q2 | -1.77 Million CAD | -132.06% |
| 2023 Q1 | -763.28 Thousand CAD | 16.0% |
| 2023 Q4 | -1.54 Million CAD | -19.05% |
| 2022 Q2 | -1.18 Million CAD | 4.16% |
| 2022 Q1 | -1.23 Million CAD | -28.81% |
| 2022 FY | - CAD | -131.11% |
| 2022 Q4 | -908.62 Thousand CAD | -9.94% |
| 2022 Q3 | -826.5 Thousand CAD | 30.37% |
| 2021 Q2 | -97.91 Thousand CAD | -6.36% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q1 | -92.05 Thousand CAD | 0.0% |
| 2021 Q4 | -961.48 Thousand CAD | -332.32% |
| 2021 Q3 | -222.4 Thousand CAD | -127.13% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bioxytran, Inc. | -3.82 Million USD | -68.239% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 90.952% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -2587.43% |
| SQZ Biotechnologies Company | -64.14 Million USD | 89.98% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -143.037% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 62.999% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 106.834% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -318.41% |
| Marizyme, Inc. | -34.28 Million USD | 81.252% |
| Genus plc | 73.7 Million USD | 108.72% |
| Pharming Group N.V. | 9.87 Million USD | 165.07% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -332.092% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -81.195% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 26.733% |
| ContraFect Corporation | -64.99 Million USD | 90.112% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -358.479% |
| IMV Inc. | -35.52 Million USD | 81.908% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -176.57% |
| ONE Bio Corp. | 13.61 Million USD | 147.212% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 86.673% |
| Mesoblast Limited | -62.38 Million USD | 89.699% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -1140.621% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 279.927% |
| Genscript Biotech Corporation | -248.71 Million USD | 97.416% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -916.276% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -181.332% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -8.401% |
| Biomind Labs Inc. | -1.03 Million USD | -521.236% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -122.208% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 10.254% |
| Skye Bioscience, Inc. | -13.54 Million USD | 52.56% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 95682.838% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 2.791% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -25607.96% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -41.995% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -65.46% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 59.502% |
| Accustem Sciences Inc. | -3.74 Million USD | -71.55% |
| EV Biologics, Inc. | -1.26 Million USD | -407.208% |
| Q BioMed Inc. | -617.62 Thousand USD | -940.592% |
| GB Sciences, Inc. | -1.41 Million USD | -352.642% |
| Alpha Cognition Inc. | -9.7 Million USD | 33.781% |
| CSL Limited | 4.78 Billion USD | 100.134% |
| Agentix Corp. | -1.37 Million USD | -368.523% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 83.785% |
| Enzolytics Inc. | -2.12 Million USD | -202.87% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -11.74 Million USD | 45.265% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -109.826% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -156.878% |
| argenx SE | -216.02 Million USD | 97.025% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 88.386% |
| HST Global, Inc. | -5303.00 USD | -121095.361% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 628.101% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -212.445% |
| Halberd Corporation | -74.27 Thousand USD | -8552.499% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 172.59% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 1796.474% |
| Zenith Capital Corp. | -8.6 Million USD | 25.32% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -328.779% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -162.706% |
| AVAX Technologies, Inc. | -6.11 Million USD | -5.143% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -3551.194% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -234.58% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -36792.199% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | -521.087% |
| Helix BioMedix, Inc. | -1.04 Million USD | -514.252% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -267.257% |
| Kadimastem Ltd | -2.62 Million USD | -144.895% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | 14.915% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -3449.098% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | 412.28 Thousand USD | 1658.878% |
| Cell Source, Inc. | -4.27 Million USD | -50.426% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -1650.17% |
| Regen BioPharma, Inc. | 1.46 Million USD | 538.416% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -585.949% |
| Affymax, Inc. | -14.29 Million USD | 55.04% |
| Mobile Lads Corp. | -2.24 Million USD | -186.771% |
| Itoco Inc. | -1.86 Million USD | -243.874% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -1593.006% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -475.895% |
| International Stem Cell Corporation | 202 Thousand USD | 3281.678% |
| CytoDyn Inc. | -18.02 Million USD | 64.352% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -8032.445% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -52455.319% |
| Qrons Inc. | -40.08 Thousand USD | -15935.004% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -1223.303% |
| SYBLEU INC | -141.57 Thousand USD | -4439.764% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 1318.542% |
| Rebus Holdings, Inc. | -951 Thousand USD | -575.814% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -505.172% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -12109.328% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -161.055% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 82.082% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -14182.2% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -134.733% |
| Neutra Corp. | -181.24 Thousand USD | -3445.984% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 68.119% |
| PureTech Health plc | -11.62 Million USD | 44.724% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 68.116% |
| IXICO plc | -707 Thousand USD | -809.051% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 16.37% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 86.706% |
| CSL Limited | 4.73 Billion USD | 100.136% |
| Cellectis S.A. | -92.63 Million USD | 93.062% |